RMD

SELL

ResMed Inc.

Healthcare · Rank #91 · Analyzed Oct 18, 2026

$238.97

Current Price

$174.52

Intrinsic Value

-27.0%

Upside/Downside

4.5/10

Score

4.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score4.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 27.0%

Fair Value Range

Low$18.33

Base (IV)$174.52

High$182.34

Entry Points

Conservative$12.83

Moderate$18.33

Aggressive$122.16

Quality & Moat Breakdown

Return on Equity24.3% → 1.0/1.0

Debt LevelD/E 13 → 1.0/1.0

Revenue QualityGrowth 5.4%, margin Δ+11.6% → 1.0/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins26.9% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.